BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 241 filers reported holding BEAM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,346,934 | $134,479,000 | 56.91% |
HSG Holding Ltd | 796,089 | $45,616,000 | 5.69% |
Redmile Group, LLC | 1,836,050 | $105,206,000 | 3.28% |
Deep Track Capital, LP | 763,750 | $43,763,000 | 2.81% |
Casdin Capital, LLC | 818,820 | $46,918,000 | 2.10% |
ARK Investment Management | 8,200,749 | $469,903,000 | 1.96% |
Nan Fung Group Holdings Ltd | 54,903 | $3,146,000 | 1.49% |
Evolutionary Tree Capital Management, LLC | 34,296 | $1,965,000 | 1.37% |
BRANDYWINE MANAGERS, LLC | 13,067 | $749,000 | 1.29% |
Temasek Holdings (Private) Ltd | 3,959,212 | $226,862,848 | 0.96% |
FARALLON CAPITAL MANAGEMENT LLC | 2,594,387 | $148,658,000 | 0.72% |
Connective Portfolio Management, LLC | 5,000 | $297,000 | 0.64% |
Polianta Ltd | 16,100 | $922,000 | 0.60% |
Alphabet Inc. | 321,604 | $18,428,000 | 0.60% |
Phoenix Wealth Advisors | 7,970 | $437,000 | 0.45% |
Neo Ivy Capital Management | 8,698 | $498,000 | 0.45% |
Eagle Health Investments LP | 28,900 | $1,656,000 | 0.41% |
HighVista Strategies LLC | 11,102 | $636,000 | 0.40% |
Cormorant Asset Management, LP | 90,045 | $5,160,000 | 0.40% |
Renaissance Capital LLC | 15,955 | $914,000 | 0.39% |
External links
This page lists BEAM THERAPEUTICS INC's shareholders in Q1 2022. To view BEAM THERAPEUTICS INC's shareholder history, click here.